Recommendation ID
NG144/7
Question

What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment in babies, children and young people with chemotherapy-induced nausea or vomiting which persists with optimised conventional antiemetics?

Any explanatory notes
(if applicable)

Source guidance details

Comes from guidance
Cannabis-based medicinal products
Number
NG144
Date issued
November 2019

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 30/11/2019